http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085648-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2015-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105085648-B |
| titleOfInvention | The correspondence antigen of ovarian cancer resistance monoclonal antibody COC166-9 and its application |
| abstract | The present invention relates to the correspondence antigen of ovarian cancer resistance monoclonal antibody COC166-9 and its applications, specifically, the present invention relates to the clone identification of the correspondence antigen (CA166-9) of ovarian cancer resistance monoclonal antibody COC166-9 and its judging the application in ovarian cancer prognosis and prevention and treatment.It is of the invention studies have shown that monoclonal antibody COC166-9 can be used for the judgement to ovarian cancer patients prognosis；The correspondence antigen of monoclonal antibody COC166-9 is IGHG1 sample albumen, can promote proliferation, migration and the invasion of tumour cell, may play an important role in the tumor development of oophoroma.The antigen is also possible to be used for the prevention and treatment of oophoroma as vaccine. |
| priorityDate | 2015-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.